Barely Significant
← all excerpts

Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.

Mol Ther · 2016 · PMC5023384 · PMID 27166877

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP ≤ 0.001actually significant
As noted, the tumor response and animal survival benefit was highly significant ( P ≤ 0.001) in all studies.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.